{
 "cells": [
  {
   "cell_type": "markdown",
   "id": "fca69035-4f75-4d1c-9590-465aed4c13a7",
   "metadata": {},
   "source": [
    "##### Canned question: Mechanism of Action (MoA) cross-results\n",
    "\n",
    "This is a simple demo showing how we can use an LLM to group results from Translator according to their mechanisms of action."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 20,
   "id": "2d8f46ac-ad73-4b69-b21e-6aa205d37401",
   "metadata": {},
   "outputs": [],
   "source": [
    "from graphwerk import trapimsg\n",
    "import summarizers.trapi_tools as tools\n",
    "import summarizers.common_utils as cu\n",
    "from driver import load_trapi_response"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 22,
   "id": "1ff5ef17-884f-4a9e-84d0-ee4fed45318e",
   "metadata": {},
   "outputs": [],
   "source": [
    "trapi_path = 'data/101635ed-6bb7-46fc-a2f1-96d814c34040.json'\n",
    "trapi_response_msg = load_trapi_response(trapi_path)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 57,
   "id": "3450d35a-5c46-4910-8d22-a20b734f6353",
   "metadata": {},
   "outputs": [],
   "source": [
    "orig_msg = trapi_response_msg['fields']['data']['message']\n",
    "orig_kg = orig_msg['knowledge_graph']\n",
    "orig_ag = orig_msg['auxiliary_graphs']\n",
    "orig_qg = orig_msg['query_graph']\n",
    "retval = ''\n",
    "object_node_id, object_node_data = tools.get_object_node_data(orig_qg, orig_kg)\n",
    "res_nodes = {} # The node section is universal, not per-result\n",
    "\n",
    "per_result = ''\n",
    "counter = 1\n",
    "# fetch the first 10 results for manually reviewing\n",
    "idx_range = range(0, min(10, len(orig_msg['results'])))\n",
    "pub_cutoff = 0\n",
    "for i in idx_range:\n",
    "    cur_res = orig_msg['results'][i]\n",
    "    subject_id = cur_res['node_bindings']['sn'][0]['id']\n",
    "    subject_name = orig_kg['nodes'][subject_id]['name']\n",
    "    per_result += f\"** Result {counter}: {subject_name}\\n\"\n",
    "    res_edges = {}\n",
    "    res_sgs = {}\n",
    "    trapimsg.collect_edges_and_sgs_for_res_elem(cur_res, orig_kg, orig_ag, res_edges, res_sgs)\n",
    "    trapimsg.collect_nodes_for_edge_collection(res_edges, orig_kg, res_nodes)\n",
    "    presum_edges = tools.create_edge_presummary_raw_data(res_edges, res_nodes, pub_cutoff)\n",
    "    presum_nodes = tools.create_node_presummary_raw_data(res_nodes)\n",
    "    per_result += cu.create_edge_data_summary(presum_edges, 1) + '\\n'\n",
    "    counter += 1"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1,
   "id": "6909def6-6b0f-4ab4-81a0-2d394f66590c",
   "metadata": {
    "scrolled": true
   },
   "outputs": [],
   "source": [
    "# print(per_result.rstrip())"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 69,
   "id": "1b0be33c-5948-4609-81ba-e013d6edb29d",
   "metadata": {},
   "outputs": [],
   "source": [
    "def generate_prompt(results):\n",
    "    if results:\n",
    "        prompt = f\"\"\"I’m not looking for detailed mechanism of actions of each drug/chemical. Please analyze the cross-result patterns across all inferred paths in the provided results: what common MoA themes, gene targets, or pathways emerge? Group the drugs/chemicals into categories based on shared mechanisms rather than listing them individually.\n",
    "Results: \n",
    "{results}\n",
    "        \"\"\"\n",
    "    else: prompt = None\n",
    "\n",
    "    return prompt"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 72,
   "id": "6aae86b7-2a0b-4786-8dfc-e2ccd54b8510",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "I’m not looking for detailed mechanism of actions of each drug/chemical. Please analyze the cross-result patterns across all inferred paths in the provided results: what common MoA themes, gene targets, or pathways emerge? Group the drugs/chemicals into categories based on shared mechanisms rather than listing them individually.\n",
      "Results: \n",
      "** Result 1: Prednisone\n",
      "| <SUBJECT> | <PREDICATE> | <OBJECT> | <PUBMED IDS> | <CLINICAL TRIAL IDS> |\n",
      "| Prednisone | treats_or_applied_or_studied_to_treat | Multiple Pulmonary Nodules |  |  |\n",
      "\n",
      "** Result 2: dexamethasone sodium phosphate\n",
      "| <SUBJECT> | <PREDICATE> | <OBJECT> | <PUBMED IDS> | <CLINICAL TRIAL IDS> |\n",
      "| dexamethasone sodium phosphate | in_clinical_trials_for | Nodule of lung |  | NCT00906503 |\n",
      "| NCF2 | gene_associated_with_condition | Nodule of lung |  |  |\n",
      "| STAT1 | gene_associated_with_condition | Nodule of lung |  |  |\n",
      "| CTLA4 | gene_associated_with_condition | Nodule of lung |  |  |\n",
      "| HLA-DPA1 | gene_associated_with_condition | Nodule of lung |  |  |\n",
      "| dexamethasone sodium phosphate | affects | NCF2 |  |  |\n",
      "| dexamethasone sodium phosphate | affects | STAT1 |  |  |\n",
      "| dexamethasone sodium phosphate | affects | CTLA4 |  |  |\n",
      "| dexamethasone sodium phosphate | affects | HLA-DPA1 |  |  |\n",
      "| Nodule of lung | occurs_together_in_literature_with | dexamethasone sodium phosphate |  |  |\n",
      "\n",
      "** Result 3: hydromorphone hydrochloride\n",
      "| <SUBJECT> | <PREDICATE> | <OBJECT> | <PUBMED IDS> | <CLINICAL TRIAL IDS> |\n",
      "| hydromorphone hydrochloride | in_clinical_trials_for | Nodule of lung |  | NCT05848635 |\n",
      "| Nodule of lung | occurs_together_in_literature_with | hydromorphone hydrochloride |  |  |\n",
      "\n",
      "** Result 4: Interferon Gamma\n",
      "| <SUBJECT> | <PREDICATE> | <OBJECT> | <PUBMED IDS> | <CLINICAL TRIAL IDS> |\n",
      "| NCF2 | gene_associated_with_condition | Nodule of lung |  |  |\n",
      "| STAT1 | gene_associated_with_condition | Nodule of lung |  |  |\n",
      "| CTLA4 | gene_associated_with_condition | Nodule of lung |  |  |\n",
      "| PTPN22 | gene_associated_with_condition | Nodule of lung |  |  |\n",
      "| HLA-DPB1 | gene_associated_with_condition | Nodule of lung |  |  |\n",
      "| HLA-DPA1 | gene_associated_with_condition | Nodule of lung |  |  |\n",
      "| Interferon Gamma | affects | NCF2 |  |  |\n",
      "| Interferon Gamma | affects | STAT1 |  |  |\n",
      "| Interferon Gamma | affects | CTLA4 |  |  |\n",
      "| Interferon Gamma | affects | PTPN22 |  |  |\n",
      "| Interferon Gamma | affects | HLA-DPB1 |  |  |\n",
      "| Interferon Gamma | affects | HLA-DPA1 |  |  |\n",
      "\n",
      "** Result 5: D-glucopyranose\n",
      "| <SUBJECT> | <PREDICATE> | <OBJECT> | <PUBMED IDS> | <CLINICAL TRIAL IDS> |\n",
      "| NCF2 | gene_associated_with_condition | Nodule of lung |  |  |\n",
      "| STAT1 | gene_associated_with_condition | Nodule of lung |  |  |\n",
      "| CTLA4 | gene_associated_with_condition | Nodule of lung |  |  |\n",
      "| HLA-DPA1 | gene_associated_with_condition | Nodule of lung |  |  |\n",
      "| D-glucopyranose | affects | NCF2 |  |  |\n",
      "| D-glucopyranose | affects | STAT1 |  |  |\n",
      "| D-glucopyranose | affects | CTLA4 |  |  |\n",
      "| D-glucopyranose | affects | HLA-DPA1 |  |  |\n",
      "\n",
      "** Result 6: Tocilizumab\n",
      "| <SUBJECT> | <PREDICATE> | <OBJECT> | <PUBMED IDS> | <CLINICAL TRIAL IDS> |\n",
      "| STAT1 | gene_associated_with_condition | Nodule of lung |  |  |\n",
      "| CTLA4 | gene_associated_with_condition | Nodule of lung |  |  |\n",
      "| PTPN22 | gene_associated_with_condition | Nodule of lung |  |  |\n",
      "| PRTN3 | gene_associated_with_condition | Nodule of lung |  |  |\n",
      "| Tocilizumab | affects | STAT1 |  |  |\n",
      "| Tocilizumab | affects | CTLA4 |  |  |\n",
      "| Tocilizumab | affects | PTPN22 |  |  |\n",
      "| Tocilizumab | affects | PRTN3 |  |  |\n",
      "\n",
      "** Result 7: Interleukin-10\n",
      "| <SUBJECT> | <PREDICATE> | <OBJECT> | <PUBMED IDS> | <CLINICAL TRIAL IDS> |\n",
      "| STAT1 | gene_associated_with_condition | Nodule of lung |  |  |\n",
      "| CTLA4 | gene_associated_with_condition | Nodule of lung |  |  |\n",
      "| PTPN22 | gene_associated_with_condition | Nodule of lung |  |  |\n",
      "| PRTN3 | gene_associated_with_condition | Nodule of lung |  |  |\n",
      "| Interleukin-10 | affects | STAT1 |  |  |\n",
      "| Interleukin-10 | affects | CTLA4 |  |  |\n",
      "| Interleukin-10 | affects | PTPN22 |  |  |\n",
      "| Interleukin-10 | affects | PRTN3 |  |  |\n",
      "\n",
      "** Result 8: Binetrakin\n",
      "| <SUBJECT> | <PREDICATE> | <OBJECT> | <PUBMED IDS> | <CLINICAL TRIAL IDS> |\n",
      "| NCF2 | gene_associated_with_condition | Nodule of lung |  |  |\n",
      "| STAT1 | gene_associated_with_condition | Nodule of lung |  |  |\n",
      "| CTLA4 | gene_associated_with_condition | Nodule of lung |  |  |\n",
      "| PTPN22 | gene_associated_with_condition | Nodule of lung |  |  |\n",
      "| Binetrakin | affects | NCF2 |  |  |\n",
      "| Binetrakin | affects | STAT1 |  |  |\n",
      "| Binetrakin | affects | CTLA4 |  |  |\n",
      "| Binetrakin | affects | PTPN22 |  |  |\n",
      "\n",
      "** Result 9: Tretinoin\n",
      "| <SUBJECT> | <PREDICATE> | <OBJECT> | <PUBMED IDS> | <CLINICAL TRIAL IDS> |\n",
      "| NCF2 | gene_associated_with_condition | Nodule of lung |  |  |\n",
      "| STAT1 | gene_associated_with_condition | Nodule of lung |  |  |\n",
      "| CTLA4 | gene_associated_with_condition | Nodule of lung |  |  |\n",
      "| PRTN3 | gene_associated_with_condition | Nodule of lung |  |  |\n",
      "| Tretinoin | affects | NCF2 |  |  |\n",
      "| Tretinoin | affects | STAT1 |  |  |\n",
      "| Tretinoin | affects | CTLA4 |  |  |\n",
      "| Tretinoin | affects | PRTN3 |  |  |\n",
      "\n",
      "** Result 10: Fluorouracil\n",
      "| <SUBJECT> | <PREDICATE> | <OBJECT> | <PUBMED IDS> | <CLINICAL TRIAL IDS> |\n",
      "| STAT1 | gene_associated_with_condition | Nodule of lung |  |  |\n",
      "| CTLA4 | gene_associated_with_condition | Nodule of lung |  |  |\n",
      "| HLA-DPB1 | gene_associated_with_condition | Nodule of lung |  |  |\n",
      "| HLA-DPA1 | gene_associated_with_condition | Nodule of lung |  |  |\n",
      "| Fluorouracil | affects | STAT1 |  |  |\n",
      "| Fluorouracil | affects | CTLA4 |  |  |\n",
      "| Fluorouracil | affects | HLA-DPB1 |  |  |\n",
      "| Fluorouracil | affects | HLA-DPA1 |  |  |\n",
      "        \n"
     ]
    }
   ],
   "source": [
    "prompt = generate_prompt(per_result.rstrip())\n",
    "print(prompt)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 71,
   "id": "5a89fd62-458d-427d-9923-b8d4def2a159",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "**Cross‑pathway overview**\n",
      "\n",
      "| Category | Core mechanism(s) | Shared gene‑targets / pathways | Representative drugs (listed as *type* rather than each name) |\n",
      "|----------|-------------------|---------------------------------|--------------------------------------------------------------|\n",
      "| **1. Glucocorticoid‑mediated transcriptional re‑pression** | Activation of the glucocorticoid receptor (GR) → recruitment of histone deacetylases & co‑repressors → suppression of NF‑κB, AP‑1, and STAT1‑driven transcription. | **STAT1, CTLA4, NCF2** (down‑regulated); also dampens HLA‑DP expression indirectly. | Prednisone, Dexamethasone (and analogues) |\n",
      "| **2. Cytokine/Immune‑checkpoint modulators that act through JAK‑STAT / CTLA4** | Exogenous cytokines or receptor antagonists alter the JAK‑STAT cascade (primarily STAT1) and/or directly influence T‑cell costimulatory molecules. | **STAT1, CTLA4, PTPN22, PRTN3** (modulated); also influence HLA‑DP genes. | Interferon‑γ, IL‑10, Tocilizumab (IL‑6R blockade), Binetrakin (neutrophil‑related), Tretinoin (retinoid‑induced gene changes) |\n",
      "| **3. Cytotoxic / anti‑proliferative agents** | Inhibit DNA synthesis or damage DNA (5‑FU) or induce differentiation (Tretinoin). | **STAT1, CTLA4, HLA‑DP** are secondary read‑outs of cell‑cycle arrest or differentiation. | Fluorouracil, Tretinoin |\n",
      "| **4. Metabolic / carbohydrate‑based immune modulation** | Simple sugars (glucose‑pyranoside) can act as ligands for lectin‑type receptors or alter cellular NADPH/NADP⁺ ratios, indirectly modulating NCF2 (oxidative burst) and STAT1 signaling. | **NCF2, STAT1, CTLA4, HLA‑DP** | D‑glucopyranose (sugar analogue) |\n",
      "| **5. Opioid‑analgesic with immunomodulatory side‑effects** | μ‑opioid receptor activation leads to altered cytokine milieu and reduced neutrophil activity (affecting NCF2). | **NCF2, STAT1** (down‑regulated); modest influence on CTLA4/HLA‑DP. | Hydromorphone hydrochloride (opioid) |\n",
      "\n",
      "---\n",
      "\n",
      "### What the patterns tell us\n",
      "\n",
      "1. **Central immune‑regulatory axis** – Across all classes, the **STAT1/CTLA4 module** is the most common pivot. Whether the drug suppresses, activates, or merely dampens this axis, it is the key read‑out for nodule‑related pathology in the lung.\n",
      "\n",
      "2. **Innate vs. adaptive overlap** – Genes such as **NCF2** (neutrophil oxidative burst) and **PRTN3** (neutrophil serine protease) link innate defenses, whereas **CTLA4, HLA‑DP, PTPN22** anchor adaptive T‑cell regulation. The shared influence suggests that the lung nodules involve a coordinated innate‑adaptive interplay.\n",
      "\n",
      "3. **Pathway convergence** –  \n",
      "   * **NF‑κB** is repressed by glucocorticoids, partially repressed by IFN‑γ/IL‑10, and indirectly modulated by 5‑FU/Tretinoin.  \n",
      "   * **JAK‑STAT** (particularly STAT1) is the downstream conduit for most cytokine/antibody actions.  \n",
      "   * **T‑cell costimulation/ checkpoints** (CTLA4) are a common downstream node, reinforcing the importance of T‑cell regulation in nodule biology.\n",
      "\n",
      "4. **Therapeutic implications** –  \n",
      "   * Drugs that **boost STAT1** (IFN‑γ) may enhance antigen presentation but could exacerbate inflammatory lesions.  \n",
      "   * Agents that **block STAT1** (glucocorticoids, 5‑FU) or **suppress CTLA4** (Tocilizumab) can dampen local immune activation, potentially controlling nodule growth.  \n",
      "   * Modulation of **innate‑cell genes (NCF2, PRTN3)** may influence the oxidative environment and neutrophil‑driven matrix remodeling.\n",
      "\n",
      "---\n",
      "\n",
      "### Take‑away\n",
      "\n",
      "- **Most drugs converge on the STAT1–CTLA4 axis**, whether by suppressing or stimulating it.  \n",
      "- **Innate‑adaptive immune checkpoints** (NCF2, PRTN3, HLA‑DP, PTPN22) are secondary but essential contributors.  \n",
      "- **Drug classes can be succinctly grouped** by their primary mechanistic theme (glucocorticoid repression, cytokine/immune‑checkpoint modulation, cytotoxic anti‑proliferation, metabolic sugar effects, opioid analgesic side‑effects).  \n",
      "\n",
      "This categorization helps in prioritising compounds for further mechanistic studies or combination therapies aimed at modulating lung nodule biology.\n"
     ]
    }
   ],
   "source": [
    "from ollama import Client\n",
    "\n",
    "client = Client()\n",
    "\n",
    "if prompt:\n",
    "    messages = [\n",
    "      {\n",
    "        'role': 'user',\n",
    "        'content': prompt,\n",
    "      },\n",
    "    ]\n",
    "    \n",
    "    response = client.chat(\n",
    "        model='gpt-oss:20b',\n",
    "        messages=messages,\n",
    "        options={'num_ctx': 8192},  # 8192 is the recommended lower limit for the context window\n",
    "      )\n",
    "\n",
    "    response_content = response['message']['content']\n",
    "else:\n",
    "    response_content = \"No prompt is provided.\"\n",
    "\n",
    "print(response_content)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "558ea2f3-7ed8-43fd-a66b-fa43bc18c439",
   "metadata": {},
   "outputs": [],
   "source": [
    "# TODO:\n",
    "# review the response from LLM\n",
    "# propose any improvement we can do"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "070f7d3a-4249-4c59-ad1d-c6b77e836c35",
   "metadata": {},
   "outputs": [],
   "source": [
    "# Next steps:\n",
    "# The input results should be limited up to 10-20(?) because of the context length / attention length limitation(?)\n",
    "# Need to include the node details if we do not want the knowledge from the traning data of a LLM\n",
    "# Possible for the user to choose the input results?\n",
    "# Tools development for LLM to fetch/retrieve better backgroud knowledge about the nodes and relations \n",
    "# from the Translator result graph. e.g. fetch gene information, gene enrichment/related genes(?), etc."
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "trapiQA",
   "language": "python",
   "name": "trapiqa"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.13.5"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 5
}
